Coronavirus live news: Trump says he ‘perhaps’ misled Americans as global deaths


Trials of Oxford University’s potential coronavirus vaccine could resume within days after being paused for an urgent investigation into possible adverse side-effects.

It is understood that Astrazeneca, the British drugmaker working with Oxford, halted new enrolment on trials after a British volunteer showed symptoms of transverse myelitis (TM), a rare inflammatory condition that affects the spinal cord.

Stat, the health industry website which first reported the hiatus, said that a woman was suspected to have TM but the diagnosis was not confirmed, and she was on course to be discharged from hospital as early as last night.



Read More: Coronavirus live news: Trump says he ‘perhaps’ misled Americans as global deaths

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

Get more stuff like this
in your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.